glp-1 ra drug names What to Make of the Coverage and Cost Landscape Mapping the effectiveness and risks

For patients with type 2 diabetes, either medication addresses both blood sugar management and weight, which is particularly relevant for the over-50 population where type 2 diabetes prevalence is significantly higher

doi:10.2337/dbi19-0023 159

FRC comprising of insulin degludec with liraglutide

The model proposes that the interaction between the C-terminal domain of the ligand with the extracellular domain (ECD) of the receptor supports the engagement of the N-terminal domain of the ligand with the central transmembrane domain of the receptor, causing a conformational rearrangement that initiates the second messenger signaling (19, 21, 42)